EC Number |
Inhibitors |
Structure |
---|
3.1.3.1 | (2Z)-2-(benzoylamino)-3-[2-[4-(trifluoromethyl)phenyl]-1-benzothiophen-3-yl]prop-2-enoate |
with 0.1 mM 35% remaining activity |
|
3.1.3.1 | (4-methoxyphenyl)[2-(4-methoxyphenyl)-1-benzothiophen-3-yl]methanone |
with 0.1 mM 70% remaining activity |
|
3.1.3.1 | (E)-N'-(1-(3-(4-fluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)ethylidene)isonicotinohydrazide |
- |
|
3.1.3.1 | (E)-N'-(4'-chlorobenzylidene)isonicotinohydrazide |
most potent inhibitor for intestinal alkaline phosphatase |
|
3.1.3.1 | (E)-N'-(4-hydroxy-3-methoxybenzylidene)isonicotinohydrazide |
most potent inhibitor for tissue-non-specific alkaline phosphatase |
|
3.1.3.1 | 1,10-phenanthroline |
1 mM, irreversibly inactivates the enzyme |
|
3.1.3.1 | 1,4-dimethoxy-2-methylbenzene |
- |
|
3.1.3.1 | 1-(2-phenyl-1-benzothiophen-3-yl)methanamine |
with 0.4 mM 76% remaining activity |
|
3.1.3.1 | 1-(3,4-dihydroxyphenyl)-2-(1H-imidazol-1-yl)ethanone |
- |
|
3.1.3.1 | 1-(3,4-dihydroxyphenyl)-2-(2-ethyl-1H-imidazol-1-yl)ethanone |
- |
|